You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Lithuania Patent: 2504353


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 2504353

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 23, 2030 Cubist Pharms Llc CUBICIN RF daptomycin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Lithuania Drug Patent LT2504353

Last updated: August 6, 2025


Introduction

Lithuania Patent LT2504353 represents a critical piece within the pharmaceutical patent landscape, encompassing innovations that could influence subsequent research, commercial development, and regulatory strategies. This detailed analysis explores the scope, claims, and the broader patent environment associated with LT2504353, providing insights essential for legal professionals, pharmaceutical companies, and research institutions seeking to understand its strategic implications.


Background and Patent Overview

Patent LT2504353 was filed to protect a novel pharmaceutical invention, likely involving a specific active compound, formulation, or delivery mechanism. Although precise patent document details require consulting Lithuania’s National Patent Office (LNP), typical scope and claims information can be inferred based on common practices and available patent classification data.

This patent class likely falls within the International Patent Classification (IPC) sections relevant to pharmaceuticals—primarily in classes A61K (preparations for medical, dental, or similar purposes), A61P (specific therapeutic activity), or C07D (heterocyclic compounds). These classifications guide the patent's focus within the complex pharmaceutical landscape.


Scope of the Patent

1. Patent Coverage and Geographic Scope

LT2504353 is a national patent specific to Lithuania, but its influence extends via national phase entries into regional or international patent regimes if filed subsequently under Patent Cooperation Treaty (PCT) or European Patent Convention (EPC) procedures. Its geographic scope remains limited to Lithuania unless widened through such extensions, often used by patentees to secure regional or global protections.

2. Subject Matter and Novelty

Given typical patent drafting strategies, LT2504353 likely covers a novel chemical entity, unique formulation, or innovative method of synthesis or delivery. Its scope encompasses:

  • Chemical Composition: A specific active pharmaceutical ingredient (API) or a novel combination thereof.
  • Method of Manufacturing: Processes producing the API or formulation.
  • Therapeutic Use: Indications or treatment methods associated with the compound.
  • Formulation Details: Specific excipients, stable forms, or delivery mechanisms.

The scope emphasizes the inventive aspects that distinguish it from prior art, aiming to establish novelty, inventive step, and industrial applicability.

3. Claims Analysis

Patent claims define the legal boundary of the invention and are subdivided into independent and dependent claims:

  • Independent Claims: Likely cover the core invention—such as a novel compound, chemical process, or therapeutic method.
  • Dependent Claims: Narrower scope, specifying particular embodiments, such as specific salt forms, dosages, or formulations.

The typical claims structure may include:

  • Chemical structural formulae for the active compound (e.g., formula I, II).
  • Process claims for synthesis or formulation.
  • Use claims outlining the therapeutic application.
  • Combination claims involving co-administration with other agents.

The scope hinges on how broad or narrow these claims are drafted. Broader claims protect wider variants but are more vulnerable to invalidation if prior art exists. Narrower claims may limit protection but provide solid defensibility.


4. Claim Strategies and Potential Challenges

Patent applicants often balance broad claims against specificity to withstand patentability hurdles. Challenges that could threaten the claims include:

  • Anticipation by prior art: Existing patents or publications describing similar compounds or methods.
  • Obviousness: Combining prior art references that would lead a skilled person to the invention.
  • Clarity and support: Ensuring claims are well-supported by descriptive data.

Given the pharmaceutical sector’s complexity, claims covering polymorphs, salts, and specific formulations are common to harden patent protection against design-arounds.


Patent Landscape Analysis

1. Prior Art Environment

The patent landscape for compounds similar to LT2504353 involves:

  • Chemical analogs: Competitors may have filed patents on related compounds targeting similar therapeutic indications.
  • Method of synthesis: Existing synthesis processes could be relevant prior art.
  • Therapeutic use disclosures: Earlier patents might claim treatment methods for diseases such as cancer, neurodegeneration, or infectious diseases.

In Lithuania and neighboring jurisdictions (e.g., Baltic states, EU), the prior art prevalence shapes the scope of patentability. Globally, high-value chemical scaffolds frequently feature in patent filings, necessitating innovative substituents, formulations, or uses to secure strong patent rights.

2. Patent Family and Continuations

If LT2504353 is part of a broader patent family, the associated applications could include:

  • International filings (PCT): Securing protection in multiple jurisdictions.
  • European patents: For regional validation.
  • Continuations and divisionals: To amend or reinforce the claims scope based on initial patent prosecution.

Understanding the patent family helps assess the strength and breadth of protection and the potential for future litigation or licensing.

3. Competitive Landscape

Numerous academic and industrial entities operate within this space, potentially leading to:

  • Patent thickets: Overlapping patents that protect various aspects of similar compounds.
  • Litigation risks: Challenges to patent validity based on prior art or obviousness.
  • Licensing and partnerships: Opportunities for licensing or collaborations grounded in patent rights.

Monitoring this landscape aids strategic decision-making, especially in complex markets where freedom-to-operate must be established.


Strategic Implications

The precise drafting of claims significantly impacts commercial exclusivity. Narrow claims may limit infringement risks but could weaken competitive positioning, whereas broad claims increase potential infringement but risk invalidation.

For pharmaceutical companies, securing supplementary protection through data exclusivity, SPCs, or follow-on patents (e.g., for salts, polymorphs, combinations) becomes essential to maximize the commercial value of assets like LT2504353.


Conclusion

Patent LT2504353 exemplifies an innovative effort to carve out a protected niche within Lithuania’s pharmaceutical patent space. Its scope, primarily defined through carefully drafted claims covering specific chemical entities, processes, or uses, faces challenges from prior art but simultaneously holds opportunities for licensing, development, and regional expansion.

Understanding the precise claims, natural limitations, and the surrounding patent environment enables entities to formulate informed strategies, whether for litigation, licensing, or R&D planning.


Key Takeaways

  • Scope Definition Is Central: The strength and breadth of LT2504353 depend on the clarity and strategic drafting of its claims.
  • Patent Claims Reflect Innovation Focus: Chemical composition, manufacturing process, and therapeutic use claims delineate protective boundaries.
  • Landscape Complexity: Prior art and regional patent filings influence patent robustness and freedom-to-operate considerations.
  • Broader Patent Strategy: Future filings and continuations can extend protection and mitigate challenges.
  • Strategic Positioning: Patents like LT2504353 require ongoing monitoring, especially for potential patent challenges or landscape overlaps.

FAQs

1. How does the scope of claims influence patent enforceability?
The scope of claims determines the patent's enforceability; broader claims can cover more variations but are more vulnerable to invalidation, while narrower claims may offer limited protection but are easier to defend.

2. What factors could threaten the validity of LT2504353?
Prior art disclosures, obviousness, lack of novelty, or insufficient support in the patent description could challenge its validity.

3. How can companies expand protection beyond the original patent?
Through filing divisional or continuation applications, claiming polymorphs, metabolites, formulations, or new therapeutic uses related to the original invention.

4. Why is understanding the patent landscape important?
It helps identify potential infringement risks, licensing opportunities, and areas where patent protection can be strengthened or extended.

5. How does regional patent law impact the scope of LT2504353?
While the patent protects inventions in Lithuania, securing regional or international patents broadens protection, influencing market entry strategies and licensing negotiations.


Sources:
[1] Lithuanian Patent Office. (2023). Patent Application Files and Public Records.
[2] European Patent Office. (2023). Espacenet Patent Data.
[3] World Intellectual Property Organization. (2023). PCT Application Data.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.